One of the things that investors need to keep in mind about small cap stocks is the fact that although these stocks are volatile, they can often generate considerable returns. This brings us to the subject of the Regen BioPharma Inc (OTCMKTS:RGBP) stock, which managed to clock gains of as much as 50% over the course of the previous week.
That said, it is also necessary to remember that there was no news about the company that might have resulted in such enormous gains. On the other hand, it is also important to note that the Regen stock started soaring back in April after it reached an agreement with KLS, its subsidiary for some licenses.
The licenses from KLS are related to intellectual property that might be deployed for the development as well as for commercialisation of treatments that are meant for pancreatic cancers.
At this point in time, Regen is working on updating its filings with the powers that be so that it can get pink current status from the OTC Markets. That is another important event in the company’s immediate future and getting the Pink Current status could also come as a boost to the Regen stock.
Market Reaction:
On Friday, RGBP stock soared 50.67% at $0.0226 with more than 266.98 million shares, compared to its average volume of 205 million shares. The stock has moved within a range of $0.0140 – 0.0238 after opening the trade at $0.0145. Over the past 52-week, the stock has been trading within a range of $ 0.0001 – 0.0819.